X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (14) 14
female (12) 12
male (12) 12
middle aged (12) 12
hematology (9) 9
adult (8) 8
index medicus (8) 8
aged (7) 7
antineoplastic combined chemotherapy protocols - therapeutic use (6) 6
disease-free survival (5) 5
oncology (5) 5
chemotherapy (4) 4
retrospective studies (4) 4
treatment outcome (4) 4
adolescent (3) 3
care and treatment (3) 3
disease (3) 3
follow-up studies (3) 3
high-dose chemotherapy (3) 3
hodgkin disease - drug therapy (3) 3
italy (3) 3
myelodysplastic syndrome (3) 3
non-hodgkins-lymphoma (3) 3
prognosis (3) 3
radiotherapy (3) 3
stem-cell transplantation (3) 3
time factors (3) 3
transplantation (3) 3
transplantation, autologous (3) 3
usage (3) 3
1st-line treatment (2) 2
abridged index medicus (2) 2
acute kidney injury - chemically induced (2) 2
aged, 80 and over (2) 2
antibodies, monoclonal - administration & dosage (2) 2
antibodies, monoclonal, murine-derived (2) 2
bone-marrow (2) 2
bone-marrow-transplantation (2) 2
cancer (2) 2
cells (2) 2
combination chemotherapy (2) 2
cyclophosphamide - administration & dosage (2) 2
cytarabine (2) 2
denmark (2) 2
dexamethasone (2) 2
diagnosis (2) 2
dosage and administration (2) 2
elderly-patients (2) 2
follow-up (2) 2
hematology, oncology and palliative medicine (2) 2
hodgkin disease - mortality (2) 2
hodgkin's disease (2) 2
journal article (2) 2
kaplan-meier estimate (2) 2
lymphoma, b-cell - mortality (2) 2
methotrexate - administration & dosage (2) 2
methotrexate - adverse effects (2) 2
positron-emission-tomography (2) 2
prognostic factors (2) 2
quality (2) 2
recurrence (2) 2
response criteria (2) 2
risk (2) 2
rituximab (2) 2
salvage therapy (2) 2
staging (2) 2
survival (2) 2
therapy (2) 2
transplantation conditioning - methods (2) 2
trial (2) 2
1st-line therapy (1) 1
acute kidney injury - complications (1) 1
acute kidney injury - epidemiology (1) 1
acute myeloid leukemia (1) 1
acute myeloid-leukemia (1) 1
acute-renal-failure (1) 1
administration, oral (1) 1
aggressive lymphoma (1) 1
algorithm (1) 1
algorithms (1) 1
allogeneic bone-marrow (1) 1
anemia - chemically induced (1) 1
angiography (1) 1
angioplasty (1) 1
antigens, cd - analysis (1) 1
antigens, differentiation, myelomonocytic - analysis (1) 1
antineoplastic agents, alkylating - administration & dosage (1) 1
antineoplastic agents, phytogenic - administration & dosage (1) 1
antineoplastic combined chemotherapy protocols - administration & dosage (1) 1
antineoplastic combined chemotherapy protocols - adverse effects (1) 1
aplastic-anemia (1) 1
attitude to health (1) 1
australia (1) 1
autografts (1) 1
autologous stem cell transplantation (1) 1
autologous transplantation (1) 1
azacitidine (1) 1
bacteria - growth & development (1) 1
bacterial contamination (1) 1
bacterial-contamination (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Haematology, The, ISSN 2352-3026, 2016, Volume 3, Issue 5, pp. e217 - e227
Summary Background Standard treatment for patients with primary CNS lymphoma remains to be defined. Active therapies are often associated with increased risk... 
Hematology, Oncology and Palliative Medicine | 1ST-LINE TREATMENT | RESPONSE CRITERIA | GUIDELINES | NON-HODGKINS-LYMPHOMA | FOLLOW-UP | CENTRAL-NERVOUS-SYSTEM | WHOLE-BRAIN RADIOTHERAPY | HIGH-DOSE CHEMOTHERAPY | STEM-CELL TRANSPLANTATION | HEMATOLOGY | Follow-Up Studies | Cytarabine - therapeutic use | Humans | Lymphoma, B-Cell - therapy | Middle Aged | Male | Comparative Effectiveness Research | Hyperglycemia - chemically induced | Radiotherapy, Adjuvant - adverse effects | Hematopoietic Stem Cell Transplantation - adverse effects | Lymphoma, B-Cell - diagnostic imaging | Transplantation Conditioning - methods | Rituximab - adverse effects | Induction Chemotherapy - methods | Anemia - chemically induced | Central Nervous System Neoplasms - therapy | Thrombocytopenia - chemically induced | Mucositis - chemically induced | Magnetic Resonance Imaging | Methotrexate - adverse effects | Dexamethasone - therapeutic use | Radiotherapy, Adjuvant - methods | Transplantation, Autologous - adverse effects | Heart Injuries - chemically induced | Italy | Hematopoietic Stem Cell Transplantation - methods | Central Nervous System Neoplasms - mortality | Germany | Thiotepa - adverse effects | Thiotepa - therapeutic use | Thrombosis - chemically induced | Intraocular Lymphoma - therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Cytarabine - adverse effects | Methotrexate - therapeutic use | Infection - chemically induced | Rituximab - therapeutic use | Stroke - chemically induced | Optic Nerve Neoplasms - diagnostic imaging | Poisoning - epidemiology | Female | Remission Induction - methods | Transplantation Conditioning - adverse effects | Acute Kidney Injury - chemically induced | Neutropenia - chemically induced | Optic Nerve Neoplasms - therapy | Death, Sudden - epidemiology | Lymphoma, B-Cell - mortality | Intraocular Lymphoma - diagnostic imaging | Kaplan-Meier Estimate | Chemical and Drug Induced Liver Injury - epidemiology | Treatment Outcome | United Kingdom | Combined Modality Therapy - adverse effects | Switzerland | Induction Chemotherapy - adverse effects | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Central Nervous System Neoplasms - diagnostic imaging | Denmark | Combined Modality Therapy - methods | Neurotoxicity Syndromes - epidemiology | Gastrointestinal Diseases - chemically induced
Journal Article
Lancet Haematology, The, ISSN 2352-3026, 2016, Volume 3, Issue 10, pp. e467 - e479
Journal Article
Cancer, ISSN 0008-543X, 07/1986, Volume 58, Issue 2, p. 229
Seventy-four consecutive patients with nonblastic chronic granulocytic leukemia (CGL) were observed from diagnosis and retrospectively studied. The patients... 
Prognosis | Erythroblasts | Humans | Middle Aged | Female | Male | Leukemia, Myeloid - mortality | Neoplasm Staging
Journal Article
Cancer, ISSN 0008-543X, 06/2003, Volume 97, Issue 11, pp. 2748 - 2759
Journal Article
Blood, ISSN 0006-4971, 12/2015, Volume 126, Issue 23, pp. 2879 - 2879
Abstract Introduction: Since its implementation in 2012, the IPSS-R (Greenberg et al., 2012), defines the latest standard in risk stratification of patients... 
Journal Article
Haematologica, ISSN 0390-6078, 09/2009, Volume 94, Issue 9, pp. 1250 - 1258
Journal Article
British Journal of Haematology, ISSN 0007-1048, 06/2017, Volume 177, Issue 5, pp. 741 - 750
Journal Article
Journal Article
Journal Article
Transfusion, ISSN 0041-1132, 07/2004, Volume 44, Issue 7, pp. 1013 - 1018
BACKGROUND:  Chronic ulcers can benefit from topical treatment with growth factors (GFs). PLT gel provides tissue regeneration‐inducing GFs. The aim of this... 
TRIAL | CELLS | SUPERNATANT | DIABETIC ULCERS | PLACEBO | STIMULATION | PROLIFERATION | GROWTH-FACTOR | HEMATOLOGY | RICH PLASMA | Skin Ulcer - therapy | Gels | Humans | Middle Aged | Male | Blood Platelets - physiology | Wound Healing | Necrosis | Pilot Projects | Female | Sternum - surgery | Aged | Retrospective Studies
Journal Article
Journal Article
Journal Article